- Market Capitalization, $K 33,368
- Shares Outstanding, K 107,639
- Annual Sales, $ 0 K
- Annual Income, $ -30,381 K
- 60-Month Beta N/A
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 2.53
|Period||Period Low||Period High||Performance|
| || |
-0.050 (-14.29%)since 08/20/21
| || |
-0.350 (-53.85%)since 06/22/21
| || |
-0.560 (-65.12%)since 09/22/20
VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of...
(MENAFN - Investor Brand Network)
The partnership will further industry growth for naturally derived psilocybin
Mycotopia Therapies, Inc. (OTC Pink: TPIA) (the "Company"), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin Supply Agreement with Havn Life Sciences (CSE: HAVN)...
Mushrooms could do magic for your health. In fact, according to researchers form Griffith University, ...
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Havn Life Sciences Inc. (CSE: (the "Company" or "Havn Life"), a biotechnology company developing natural health products and innovative...
Psychedelics, like psilocybin could soon revolutionize the treatment of mental and health issues, including ...
HAVN Life will export to Delic Labs in Canada for quality control and testing. This makes HAVN Life the first in the Caribbean Community and Common Market to export psilocybin.
With FBA designation, the Company continues to grow its retail footprint by partnering with the world's largest ecommerce site
The Agreement with P.A. Benjamin Manufacturing Company whom operates a GMP compliant facility in Jamaica
|3rd Resistance Point||0.362|
|2nd Resistance Point||0.343|
|1st Resistance Point||0.322|
|1st Support Level||0.282|
|2nd Support Level||0.263|
|3rd Support Level||0.242|